Navigation Links
Keryx Biopharmaceuticals Announces Additions to Management Team
Date:2/15/2008

ity office, as well as manufacturing operations in Puerto Rico, Indiana, and Brooklyn, New York as well as global responsibility for outsourced contract operations. Mr. DeBergalis received a B.S. from Fordham University in chemistry, as well as graduate degrees in chemistry and business from Canisius College, and Indiana State University, respectively.

As Vice President, Medical Affairs, Dr. Grossman will build and manage the Medical Affairs and Medical Information functions. Key components of this role include creation of phase 3 and 4 clinical development strategy and management of clinical trials; partnering with Commercial Operations to craft optimal medical commercialization strategy and to ensure expert medical support of new product commercialization; starting a medical information unit to respond to physician and patient inquiries, and development of medical liaison support.

Most recently, Dr. Grossman was Medical Director of the New York Organ Donor Network. Prior to that, Dr. Grossman was at Pfizer Inc. for over 8 years during which time he served as Medical Group Leader, Cardiovascular, Metabolic and Sexual Health. In that role he had oversight of clinical trials, regulatory, educational and promotional activities for some of the biggest pharmaceuticals at Pfizer, including Norvasc and Viagra.

Dr. Grossman, a board-certified nephrologist, received his bachelor's degree with honors from the University of Chicago and his medical degree from the Pritzker School of Medicine at the University of Chicago. After completing his internal medicine residency at Tufts-New England Medical Center in Boston, Dr. Grossman completed a research and clinical fellowship in nephrology at Brigham and Women's Hospital and Harvard Medical School. Dr. Grossman has had faculty appointments at Harvard Medical School, University of Rochester School of Medicine and NYU Medical School.

About Keryx Biopharmaceuticals, Inc.

Keryx Biopharmaceuticals, In
'/>"/>

SOURCE Keryx Biopharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Keryx Biopharmaceuticals Announces Upcoming Corporate Presentations
2. Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2007 Financial Results
3. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Third Quarter 2007 Financial Results on Thursday, October 25, at 8:30 A.M. EDT
4. Keryx Biopharmaceuticals, Inc. Enters into Licensing Agreement with Japan Tobacco and Torii Pharmaceutical for Development and Commercialization of Hyperphosphatemia Drug in Japan
5. Keryx Biopharmaceuticals, Inc. Announces Conference Call to Discuss Strategic Alliance
6. Keryx Biopharmaceuticals, Inc. Announces Appointment of Michael P. Tarnok to Board of Directors
7. Keryx Biopharmaceuticals to Present at Bank of America Investment Conference
8. XTL Biopharmaceuticals to Present at the 10th Annual BIO CEO & Investor Conference
9. Nabi Biopharmaceuticals to Present at the BMO Capital Markets Focus on Healthcare Conference
10. China Biopharmaceuticals Holdings Announces Third Quarter 2007 Financial Results
11. Nabi Biopharmaceuticals Stockholders Approve Asset Sale
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/30/2015)... The following is an open letter sent April 30, 2015 ... (NYSE: CO ) from Jayhawk Capital. We ... China Cord Blood Corp (" China Cord ") will REJECT ... Golden Meditech Holdings Co Ltd ("Golden Med"). Certainly, a going ... Med and Mr. Kam, the Chairman of both China ...
(Date:4/30/2015)... Calif. , April 30, 2015  Asterias Biotherapeutics, ... the emerging field of regenerative medicine, today announced that ... on Thursday, May 7, 2015 after the close of ... conference call and webcast on Thursday, May 7, 2015 ... discuss the results and recent corporate developments. ...
(Date:4/30/2015)... SAINT-MALO, FRANCE (PRWEB) April 30, 2015 ... States and at http://www.lespausa.com , Phytomer’s ... to sensitive and reactive skin while battling the ... inflammation. This restorative cream is formulated with star ... derived via biotechnology in a complex of soothing ...
(Date:4/29/2015)... (PRWEB) April 30, 2015 According ... Equipment Market by Product (Portable & Non-Portable), Component ... Defense, Automotive, Chemical, Metal & Mining, & Others), ... total market is expected to reach $1,453.76 Million ... Browse 71 market data tables and 92 figures ...
Breaking Biology Technology:April 30, 2015 Open Letter to the Board of China Cord Blood Corp from Jayhawk Capital 2April 30, 2015 Open Letter to the Board of China Cord Blood Corp from Jayhawk Capital 3April 30, 2015 Open Letter to the Board of China Cord Blood Corp from Jayhawk Capital 4April 30, 2015 Open Letter to the Board of China Cord Blood Corp from Jayhawk Capital 5Asterias Biotherapeutics to Report First Quarter Results on May 7, 2015 2Asterias Biotherapeutics to Report First Quarter Results on May 7, 2015 3Phytomer introduces DOUCEUR INTEMPORELLE Restorative Shield Cream 2Phytomer introduces DOUCEUR INTEMPORELLE Restorative Shield Cream 3Vibration Monitoring Equipment (Portable & Non-Portable) Market worth $1,453.76 Million by 2020 - New Report by MarketsandMarkets 2Vibration Monitoring Equipment (Portable & Non-Portable) Market worth $1,453.76 Million by 2020 - New Report by MarketsandMarkets 3Vibration Monitoring Equipment (Portable & Non-Portable) Market worth $1,453.76 Million by 2020 - New Report by MarketsandMarkets 4
... LaserGen, Inc., a DNA sequencing technology company, announced ... make an equity investment in the company. Prompting ... commercialize its novel reversible terminator chemistry, Lightning ... anticipates bringing its chemistry as reagent kits to ...
... Inc. announced today that it has entered into ... NYSE: SNY ), providing the global ... platform for the research, development and commercialization of ... (ADCC). "We are extremely pleased about our partnership ...
... German . , Leipzig: Research and industry ... as their application in research, medical diagnosis and treatment, ... for use in environmental analysis because their characteristics enable ... as a key fits a lock. In a new ...
Cached Biology Technology:SeqWright to Invest in LaserGen's Novel Lightning Terminators(TM) 2BioWa Announces License of POTELLIGENT(R) Technology to sanofi-aventis 2Fitting pieces for biosensors 2Fitting pieces for biosensors 3Fitting pieces for biosensors 4
(Date:4/14/2015)... April 14, 2015 NXT-ID, Inc. (NASDAQ: ... company focused on the growing mobile commerce market, announces ... the 2015 New York Design Awards under the category  ... York City Design Awards are part of a global ... 2,500 ratings from the marketplace, industry and judging panel. ...
(Date:4/9/2015)... 2015 Synaptics Inc. (NASDAQ: SYNA ), a ... it will report financial results for the third quarter ... the close of market. The company will host a ... p.m. PT (5:00 p.m. ET), during which management may ... the live call, analysts and investors should dial 888-438-5524 ...
(Date:4/2/2015)... At its 2015 ACMG Annual Clinical Genetics ... the American College of Medical Genetics and Genomics (ACMG) ... Board.  Members of the ACMG Board of Directors serve ... advancing its policies and programs. ACMG is the national ... an eventful time in medical genetics and genomics.  We ...
Breaking Biology News(10 mins):NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 2NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 3Synaptics to Report Third Quarter Results on April 23 2American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 2American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 3American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 4American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 5American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 6American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 7American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 8
... in determining a leaf,s venation pattern, according to ... the open-access journal PLoS Computational Biology. The researchers ... of venation patterns, based on the assumption that ... These distortions appear due to the elastic stresses ...
... dramatic improvement in cheap solar cells now being developed in ... clumped into much larger porous spheres researchers at the ... than double the efficiency of converting solar energy to electricity. ... the national meeting of the American Chemical Society. ...
... Professor John Bell said QUT had worked with a Canberra-based ... as both windows and energy generators in houses or commercial ... a significant difference to home and building owners energy costs ... stored on onsold. Professor Bell said the glass was ...
Cached Biology News:Popcorn-ball design doubles efficiency of dye-sensitized solar cells 2
...
Human Cystatin A MAb (Clone 224705)...
... Molecular Probes is pleased to offer ... the ultrasensitive detection of primary amines. ... Indiana University, the ATTO-TAG reagents are ... (OPA), naphthalene-2,3-dicarboxaldehyde (NDA) and anthracene-2,3-dicarboxaldehyde, all ...
...
Biology Products: